ReShape Lifesciences, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of RSLS for the last quarter is 1.94 M USD, and it's 1.92% lower compared to the previous quarter. The net income of Q1 24 is -2.19 M USD.